Targeting the Androgen Receptor with Steroid Conjugates: Miniperspective

[Image: see text] The androgen receptor (AR) is a major therapeutic target in prostate cancer pharmacology. Progression of prostate cancer has been linked to elevated expression of AR in malignant tissue, suggesting that AR plays a central role in prostate cancer cell biology. Potent therapeutic age...

Descripción completa

Detalles Bibliográficos
Autores principales: Levine, Paul M., Garabedian, Michael J., Kirshenbaum, Kent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207530/
https://www.ncbi.nlm.nih.gov/pubmed/24936953
http://dx.doi.org/10.1021/jm500101h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207530/
https://www.ncbi.nlm.nih.gov/pubmed/24936953
http://dx.doi.org/10.1021/jm500101h

Ejemplares similares